$0.46
Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial
Overview
52-week range
$0.30
$2.00
9% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-1.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 8, 2026 | Mar/2026 | $-0.11 | — | — | +26.7% | +2.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.13 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.10 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.15 | — | — | — | -4.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.23 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.14 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.31 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.11 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | — | -$0.10 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14,950 | — | $18,149 | $70,588 | $41,015 | — | $36,031 | $26,840 |
| Cost of revenue | $1,817 | — | $3,948 | $22,838 | $13,558 | — | $12,694 | $7,247 |
| Gross profit | $13,133 | — | $14,201 | $47,750 | $27,457 | — | $23,337 | $19,593 |
| Operating income | $-2M | — | $-2M | $-2M | $-2M | — | $-3M | $-1M |
| Net income | $-2M | — | $-2M | $-2M | $-2M | — | $-2M | $-1M |
| EPS (diluted) | $-0.11 | — | $-0.13 | $-0.10 | $-0.15 | — | $-0.23 | $-0.17 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1M | $654,783 | $590,075 | $431,320 | $622,029 | $574,485 | $81,421 | $848,796 |
| Inventory | $179,489 | $131,473 | $160,225 | $172,974 | $175,253 | $174,578 | $158,375 | $145,141 |
| Total current assets | $3M | $4M | $5M | $6M | $3M | $4M | $5M | $1M |
| Total assets | $4M | $5M | $5M | $7M | $3M | $4M | $5M | $2M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $808,364 | $887,333 | $357,524 | $600,584 | $574,736 | $546,694 | $299,389 | $212,104 |
| Total equity | $3M | $4M | $5M | $6M | $2M | $4M | $5M | $1M |
Implied volatility — last 90 days
No IV snapshots yet for NXL.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.